Complete remission in a patient with hypoplastic acute lymphoblastic leukemia induced by granulocyte-colony-stimulating factor

Acta Haematol. 1995;94(1):39-43. doi: 10.1159/000203969.

Abstract

We report here a case of hypoplastic leukemia with T cell markers in whom complete remission was obtained with granulocyte-colony-stimulating factor (G-CSF) alone. A 23-year-old male was diagnosed with hypoplastic leukemia: Hb 2.6 g/dl, platelet count 29.0 x 10(9)/l after transfusion, WBC 2.9 x 10(9)/l, hypocellular bone marrow with 70.7% blasts. He was given G-CSF 300 micrograms/day by intravenous drip infusion without antileukemic agents for severe pneumonia. After the administration of G-CSF for 15 days, hematological examination and bone marrow findings had improved to normal, and complete remission was obtained. However, the patient relapsed 45 days after discontinuation of G-CSF. The characteristics of the relapsed leukemia cells were similar to those on admission: negative for myeloperoxidase and positive for T cell markers (CD2 and CD7). The possibilities for the differentiation of leukemic cells and the recovery of normal hematopoiesis with G-CSF are discussed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antigens, CD / analysis
  • Antigens, CD7
  • Antigens, Differentiation, T-Lymphocyte / analysis
  • Biomarkers, Tumor / analysis
  • Bone Marrow / pathology
  • CD2 Antigens / analysis
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Immunophenotyping
  • Male
  • Peroxidase / analysis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Recurrence
  • Remission Induction*

Substances

  • Antigens, CD
  • Antigens, CD7
  • Antigens, Differentiation, T-Lymphocyte
  • Biomarkers, Tumor
  • CD2 Antigens
  • Granulocyte Colony-Stimulating Factor
  • Peroxidase